These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 14616792

  • 1. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
    Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Nakamura K, Takekoshi T, Kishimoto M, Mitsui H, Torii H, Komine M, Asahina A, Tamaki K.
    Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
    [Abstract] [Full Text] [Related]

  • 2. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Komine M, Asahina A, Tamaki K.
    Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
    [Abstract] [Full Text] [Related]

  • 3. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A.
    Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
    [Abstract] [Full Text] [Related]

  • 4. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis.
    Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW, Chantry D, Suzuki R, Yoshie O.
    J Allergy Clin Immunol; 2002 Jul; 110(1):139-46. PubMed ID: 12110833
    [Abstract] [Full Text] [Related]

  • 5. Analysis of eotaxin 1/CCL11, eotaxin 2/CCL24 and eotaxin 3/CCL26 expression in lesional and non-lesional skin of patients with atopic dermatitis.
    Owczarek W, Paplińska M, Targowski T, Jahnz-Rózyk K, Paluchowska E, Kucharczyk A, Kasztalewicz B.
    Cytokine; 2010 May; 50(2):181-5. PubMed ID: 20236835
    [Abstract] [Full Text] [Related]

  • 6. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 7. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H, Takahashi M, Nakamura K, Kaneko F.
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [Abstract] [Full Text] [Related]

  • 8. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children.
    Leung TF, Ma KC, Hon KL, Lam CW, Wan H, Li CY, Chan IH.
    Pediatr Allergy Immunol; 2003 Aug; 14(4):296-301. PubMed ID: 12911508
    [Abstract] [Full Text] [Related]

  • 9. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.
    Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T, Harada S, Fukunaga A, Chantry D, Gray PW, Morita A, Suzuki R, Tezuka T, Ichihashi M, Yoshie O.
    Int Immunol; 2002 Jul; 14(7):767-73. PubMed ID: 12096036
    [Abstract] [Full Text] [Related]

  • 10. CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.
    Provost V, Larose MC, Langlois A, Rola-Pleszczynski M, Flamand N, Laviolette M.
    J Leukoc Biol; 2013 Aug; 94(2):213-22. PubMed ID: 23532518
    [Abstract] [Full Text] [Related]

  • 11. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
    Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Asano N, Mitsui H, Tada Y, Wakugawa M, Watanabe T, Torii H, Komine M, Asahina A, Nakamura K, Tamaki K.
    J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
    [Abstract] [Full Text] [Related]

  • 12. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y, Takehara K, Sato S.
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [Abstract] [Full Text] [Related]

  • 13. Clinical Usefulness of Simultaneous Measurement of the Tear Levels of CCL17, CCL24, and IL-16 for the Biomarkers of Allergic Conjunctival Disorders.
    Shoji J, Aso H, Inada N.
    Curr Eye Res; 2017 May; 42(5):677-684. PubMed ID: 27897453
    [Abstract] [Full Text] [Related]

  • 14. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
    Hashimoto S, Nakamura K, Oyama N, Kaneko F, Tsunemi Y, Saeki H, Tamaki K.
    J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
    [Abstract] [Full Text] [Related]

  • 15. Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis.
    Holm JG, Hurault G, Agner T, Clausen ML, Kezic S, Tanaka RJ, Thomsen SF.
    Dermatology; 2021 Nov; 237(4):513-520. PubMed ID: 33730733
    [Abstract] [Full Text] [Related]

  • 16. Cytokine-stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26).
    Heiman AS, Abonyo BO, Darling-Reed SF, Alexander MS.
    J Interferon Cytokine Res; 2005 Feb; 25(2):82-91. PubMed ID: 15695929
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.
    Günther C, Wozel G, Meurer M, Pfeiffer C.
    Clin Exp Immunol; 2011 Nov; 166(2):145-53. PubMed ID: 21985360
    [Abstract] [Full Text] [Related]

  • 18. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
    Fujisawa T, Nagao M, Hiraguchi Y, Katsumata H, Nishimori H, Iguchi K, Kato Y, Higashiura M, Ogawauchi I, Tamaki K.
    Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
    Hon KL, Leung TF, Ma KC, Li AM, Wong Y, Fok TF.
    Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of CCL11, CCL24, and CCL26-induced degranulation in HL-60 eosinophilic cells by specific inhibitors of MEK1/MEK2, p38 MAP kinase, and PI 3-kinase.
    Badewa AP, Heiman AS.
    Immunopharmacol Immunotoxicol; 2003 May; 25(2):145-57. PubMed ID: 12784909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.